Alnylam Pharmaceuticals
ALNY
ALNY
781 hedge funds and large institutions have $42.4B invested in Alnylam Pharmaceuticals in 2026 Q1 according to their latest regulatory filings, with 103 funds opening new positions, 319 increasing their positions, 254 reducing their positions, and 154 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
18% less capital invested
Capital invested by funds: $51.7B → $42.4B (-$9.26B)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
33% less first-time investments, than exits
New positions opened: 103 | Existing positions closed: 154
Holders
781
Holding in Top 10
3
Calls
$450M
Puts
$205M
Top Buyers
| 1 | +$1.17B | |
| 2 | +$916M | |
| 3 | +$546M | |
| 4 |
Two Sigma Investments
New York
|
+$468M |
| 5 |
ClearBridge Investments
New York
|
+$258M |
Top Sellers
| 1 | -$1.87B | |
| 2 | -$450M | |
| 3 | -$448M | |
| 4 |
Invesco
Atlanta,
Georgia
|
-$297M |
| 5 |
1832 Asset Management
Toronto,
Ontario, Canada
|
-$175M |
